Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $92.2M invested in Corvus Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.86% less ownership
Funds ownership: 87.69% → 85.83% (-1.9%)
58% less capital invested
Capital invested by funds: $219M → $92.2M (-$127M)
Holders
61
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$974K | |
| 3 | +$545K | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$523K |
| 5 |
TI
Telemetry Investments
New York
|
+$496K |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$1.64M | |
| 3 | -$955K | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$710K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$642K |